← SynDRA
BD-1063
SynDRA canonical compound SYN0087050 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | SIGMAR1 |
| Mechanism of action | Sigma receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Sigma receptor antagonist
- SIGMAR1 ANTAGONIST
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- 1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine
- BD 1063
- BD1063
- 5X4CA32SG5
- 1-(2-(3,4-Dichlorophenyl)ethyl)-4-methylpiperazine
- RefChem:421044
- 1-[2-(3,4-Dichloro-phenyl)-ethyl]-4-methyl-piperazine
- Tocris-0883
- NCGC00024844-01
- SCHEMBL467155
- orb2647301
- SCHEMBL29472420
- CHEBI:92519
- GTPL12125
- SUIZRDJCBVPASY-UHFFFAOYSA-N
- BDBM50044725
- EBC-80307
- NCGC00024844-02
- DB-390556
- [1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine
- BRD-K29668683-300-01-4
- BRD-K29668683-300-02-2
- Piperazine, 1-[2-(3,4-dichlorophenyl)ethyl]-4-methyl-
- 1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine
- EX-A1959
- BD1063 dihydrochloride
- FB18147
- SCHEMBL30570469
- T7488
- 1-(3,4-dichlorophenethyl)-4-methylpiperazine dihydrochloride
- AC-35526
- BD1063 (dhydrochloride)
- GIA99613
- GLXC-07034
- BD 1063 Dihydrochloride
- BD1063 dhydrochloride?
- SR-01000597944-1
- SR-01000597944
- HY-18101A
Look up BD-1063 in the interactive SynDRA portal →